Where is the company registered?
33 ARCH ST, BOSTON, Massachusetts 02110, United States
Registered location from SAM.gov; award performance locations may differ.
Active
Overview
- Legal name
- ARGENX US, INC
- Registered location
- BOSTON, MA, USA
- Website
- Company website ↗
- Primary NAICS
- 325412 — Pharmaceutical Preparation Manufacturing
- Latest award activity
- Not available
Read company summary
ARGENX US, INC is associated with UEI YQQMVL36XZ11 and CAGE 94MS5 in public federal records. AcornBids currently links 0 prime awards totaling $0 in obligations to this entity. Its primary SAM.gov NAICS is 325412 (Pharmaceutical Preparation Manufacturing). Its public SAM.gov registration lists BOSTON, MA, USA.
At a glance
Lifetime prime obligations$0
Prime awards0
Awards with future end dates0
Top-agency concentration
Not available
Why this customer concentration
Detailed agency totals are not available in this stored profile.
Largest positive coded-agency total ÷ all positive coded-agency totals × 100
Missing data is shown as unavailable.
Prime contract obligations across loaded award records. Obligations are not revenue or contract ceilings. Summary updated Oct 19, 2026. Refresh pending; these totals may be out of date.
Business information
Public SAM.gov registration details.
- Legal name
- ARGENX US, INC
- UEI
- YQQMVL36XZ11
- CAGE
- 94MS5
- Registered address
- 33 ARCH ST, BOSTON, MA, 02110, USA
- Registration status
- Active
- Primary NAICS
- 325412 — Pharmaceutical Preparation Manufacturing
- SAM activation
- Nov 21, 2025
- Initial registration
- Jun 14, 2021
- Entity start
- Oct 10, 2017
- SAM updated
- Nov 21, 2025
- Registration expires
- Nov 19, 2026
- Fiscal year end
- Dec 31
- Place of incorporation
- DE, USA
Research brief
Source facts
- Loaded prime-award records link 0 awards and $0 in reported obligations to this legal entity. Source
Federal award analysis
Net transaction obligations by federal fiscal period.
Transaction history is not available in the loaded data. Annual funding is not estimated from current award totals.
Recent federal awards
Prime contract awards. Select an award to review its history and source evidence.
No matching records in the loaded data.
Registration, certifications & contacts
| Registration evidence | Date |
|---|---|
| SAM updated | Nov 21, 2025 |
| Source loaded | Sep 26, 2026 |
| Initial registration | Jun 14, 2021 |
| Entity start | Oct 10, 2017 |
| Industry | Reported size status |
|---|---|
| 325412 — Pharmaceutical Preparation Manufacturing | Not reported |
| 325414 — Biological Product (except Diagnostic) Manufacturing | Not reported |
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| RENE K EDWARDS | Government business | Contact method not published | SAM registration | Not available |
| DEBORAH O'DONNELL | Electronic business | Contact method not published | SAM registration | Not available |
Registered industries
- 325412 — Pharmaceutical Preparation Manufacturing
- 325414 — Biological Product (except Diagnostic) Manufacturing
Registration classifications and published certificates do not by themselves establish eligibility for a particular solicitation. View SAM source
About ARGENX US, INC
What is its primary registered industry?
325412 — Pharmaceutical Preparation Manufacturing.
Primary SAM.gov NAICS classification.
Data coverage and methodology
Sources: SAM.gov registration, USAspending awards and transactions, and linked supporting records. Prime contract obligations, IDV ceilings and assistance amounts are kept separate. Missing records are not zero activity. Company claims are labeled separately. Recompete signals are rule-based scores out of 100. Positioning windows are AcornBids estimates.
Disclosed relationships only. Missing records do not establish that a contractor has no partners. Ambiguous parent award identifiers are excluded.
Recently viewed companies
Keep your research moving
Save this company, track changes, and evaluate upcoming work against your targets.
Save to my research Find my fit